and it is an important reason for multi-drug resistant tuberculosis.
Factors such as poor administrative control on purchase and distribution of the drugs with no proper mechanism on quality control and bioavailability tests is another reason for the emergence of drug resistant Tuberculosis. 2 There is a considerable risk of amplification of drug resistance if MDR TB is treated with the first line drugs. Resistance can be reduced and prevented with complete, adequate and regular treatment. The study envisaged to find out such factors and will recommend modifications to be implemented in the TB control program.
Multidrug-resistant tuberculosis (MDR-TB) has been defined as the resistance of Mycobacterium tuberculosis strains to both isoniazid (INH) and rifampicin (RMP) with or without simultaneous resistance to other drugs. 1 MDR-TB poses a therapeutic and infection control challenge with significantly higher rates of morbidity and mortality.
MDR-TB has substantial economic implications of high treatment cost which is nearly 100 times the cost of treating a susceptible TB case. A worldwide assessment in 35 countries revealed an overall prevalence of MDR-TB as 12.6% for single-drug resistance (range, 2.3-42.4%) and 2.2% for multidrug resistance (range, 0-22.1%) in all the countries surveyed. About 50 million people were infected with multidrug resistant M. tuberculosis strains globally, and they account for 14% of the world's total TB cases. 1 India has the second highest burden of MDR-TB cases following China and it is reported that the country has approximately 66,000 MDR-TB cases among notified pulmonary TB cases in 2011 (new cases -21,000 with a range of 15,000-27,000 and retreatment cases -45,000 with a range of 40,000-50,000). A study conducted by Balaji et al on risk factors for MDR-TB in a tertiary referral hospital in India revealed that previous treatment with an injectable and Fluoroquinolone was strongly associated with MDR-TB. Smoking and Alcohol were negatively associated with MDR-TB. Residence outside the state showed a trend towards association. 4 In another study by Kliiman et al conducted in Estonia, a European country with one of the highest MDR-TB and XDR-TB rates in the world, revealed that the risk factors for poor treatment outcome in MDR-TB were HIV infection, previous TB treatment, resistance to Ofloxacin and positive acid-fast bacilli (AFB) smear at the start of treatment. 7 Li et al conducted a 1:1:1 matched-pairs case-control study in 2011 to identify predictors associated with primary MDR-TB and primary DS-TB against the control in Jiangsu Province, China. All three groups were geographically matched (by neighbourhood) and matched on sex and age (±5 years). In total, 110 participants were enrolled in each of three matched groups. Conditional logistic regression analysis showed that predictors independently associated with primary MDR-TB were illiteracy or primary school education, annual per capita income ≤US$2,000, per capita living space <40 m (2), and interval ≥7 days of eating fruits; predictors with primary DS-TB were body mass index ≤20 and feeling higher life pressure. 8 In another study conducted by Mittal and Gupta on non-compliance to DOTS in Agra city revealed that more defaulters were in the age group of greater than 45 years (22.8%), male (18.7%), retreatment cases (30.6%) with important reasons being side effects following medication, improvement in symptoms and lack of time.
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Objectives of the study 1. To identify the factors associated with MDR-TB in the setting of district Shimla, Himachal Pradesh, India. 2. To recommend modifications, based on the study findings to be implemented in the current TB Control programme.
METHODS

Source of data
Multi Data from tuberculosis patients registered and records at DOTS in TU, Shimla.
Study design
A pilot case-control study.
Study period
All patients registered between 1 st January 2013 to 30 th June, 2014 in the TU were included in the study. Triple the number of controls was enrolled after matching geographical location, gender and age ±5 years.
Sample size
Subjects: All patients who fulfilled the inclusion criteria were enrolled for the study i.e. 8 (eight).
Controls: 24 (twenty four) -who have completed DOTS and have been declared cured.
Method of collection of data
After obtaining permission from the District Tuberculosis Officer, all the patients on ATT for MDR-TB in Shimla TU who fulfilled the inclusion criteria were taken as study subjects. They were included in the study after obtaining written informed consent. After the registration of the patient, primary data (socio-demographic profile, medical history) was collected by the investigator from the patient using a semi structured and pretested questionnaire. The secondary data (sputum exam report, category of treatment, DOTS provider details) was collected from the records maintained at the DOTS centres. 
Data analysis
The data was entered in the Microsoft Excel sheet. For descriptive statistics, mean and SD were calculated. Compared with controls, risk factors with crude and adjusted matched ORs and their 95% CIs associated with primary MDR-TB were identified by univariate and multivariate logistic regression models, respectively using Epi-Info v7 software.
Inclusion criteria
All patients registered for treatment for MDR-TB (subjects) and those who have been declared cured (Controls) in TU, Shimla and who gave written informed consent.
Exclusion criteria
Those patients who are not willing to participate in the study and MDR patients who have died before the onset of the study.
RESULTS
A total of 8 primary MDR-TB and 24 controls were enrolled in the study. The groups were matched for geographical location, gender and age ±5 years. The overall mean age in the age group 15-45 was 29.5 years (SD =8.6 years) and 50% of the cases and controls were males and females respectively. The mean ages of cases and controls were 28.63 (SD =8.68) and 29.79 (SD =8.75) respectively. 
DISCUSSION
Prevalence of MDR-TB reflects the functional state and efficacy of TB control programmes and realistic attitude of the community towards implementation of such programmes. 3 Our study envisaged to explore the different risk factors associated with MDR-TB in this part of the country which has a considerable load of TB patients.
Various studies have found significant association between female gender and MDR-TB. Since our study was matched for gender, age groups and geographical locations, it is not possible to report such associations.
Various studies conducted in China and India, which contribute to a sizeable burden of the disease worldwide, found small living space, poor education and poor nutrition which orient towards a poor socio-economic status, to be associated with the disease. 7, 8 Our study has found illiteracy, low SES and poor ventilation to be associated with MDR-TB as compared to drug sensitive TB.
No significant associations were seen between MDR-TB and habits such as smoking and alcoholism in our study. This might be due to 'reporting biases' associated with these personal issues which respondents may tend to conceal. Many studies in India and abroad have reported different associations with smoking and alcohol. [10] [11] [12] [13] [14] In our opinion, there is a need to explore different methodologies regarding such inquiries into behavioural aspects, to retrieve more authentic information. 
Controls Case
The present study has found a significant association with the absence of a BCG scar in the patients suffering from MDR-TB which strengthens the version that the vaccine prevents one from the severe form of the disease. It also provides a starting point from which further extensive studies may be carried out to establish the role of the vaccine.
Antimicrobial resistance in the form of multidrugresistant TB (MDR -TB) has emerged as a major threat to global TB control efforts in recent years.
Various Indian studies have established association of MDR-TB with history of initial defaulting, inadequate initial regimen not conforming to the national guidelines and an initial treatment with an injectable and Fluoroquinolones. [15] [16] [17] In our study, initial default has found to be significantly associated with the disease whereas initial treatment from a private practitioner has emerged as an independent risk factor for the emergence of drug resistant tuberculosis further reiterating the need for strengthening early diagnosis and treatment aspect of the disease involving private practitioners which at many times are the first point of contact for the patient, so that the looming epidemic of drug resistance is contained.
The limitations of the present study have been a small sample size with a possible recall bias especially with regards to previous initial treatment history. Hence, large and more extensive studies are called for to examine the role of these risk factors in the emergence of MDR-TB.
CONCLUSION
The pilot Case control study conducted in TU-Shimla identified factors c0-with MDR-TB, which included illiteracy, poor socioeconomic status, poor ventilation, absence of BCG scar, history of initial default and initial treatment from a private practitioner. It can be inferred from these findings that Immunisation services and sensitisation of private practitioners regarding early diagnosis and treatment may be needed to be strengthened for better control of emergence and transmission of MDR-TB. Regulation of unabated sale of Anti-Tuberculosis drugs by private practitioners and chemists needs to be strictly implemented.
